ADA2 p.Ser205Leu
c.614C>T · rs369306297 · VCV1430337
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1011 | likely benign |
|---|---|---|
| REVEL | 0.246 | benign-leaning |
| SaProt | LLR -9.17 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>T here scores Δ0.29 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 3.4 | GERP -0.13, phastCons 0.42 |
| Overall | ||
| CADD | 15.1 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.00338% | 29,604 |
| Admixed Americangrpmax | 0.00333% | 29,994 |
| European (non-Finnish) | 0.00229% | 43,703 |
| East Asian | 0.00223% | 44,890 |
| South Asian | 0.0011% | 91,074 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ADA2
- Protein
- p.Ser205Leu
- Coding
- c.614C>T
- MANE Select
- NM_001166105 · reported on NM_001282225
- dbSNP
- rs369306297
- Type
- single nucleotide variant
- Location
- chr22:17203702 (GRCh38)
- Structure
- AlphaFold pLDDT 85.04 · 1 PDB
Disease context
deficiency of adenosine deaminase 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Sneddon syndrome
For Deficiency of adenosine deaminase 2 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- ADA2 p.Ser205= Likely benign ★★ same residue
- ADA2 c.754-2A>G Likely pathogenic ★★ same condition
- ADA2 c.882-2A>G Pathogenic ★★ same condition
- ADA2 c.973-2A>G Pathogenic ★★ same condition
- ADA2 p.Arg169Gln Pathogenic/Likely pathogenic ★★ ⚠ same condition
- ADA2 p.Arg169Trp Pathogenic/Likely pathogenic ★★ same condition
- ADA2 p.Arg306Ter Likely pathogenic ★★ same condition
- ADA2 p.Arg312Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ada2-p-ser205leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown